4198
欣大健康
-0.50 (-1.02%)48.301成交張數–本益比5.71股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 4 | 2 | 28.7% | 2.85 | 8.46 | -18.2% | -11.2% | -0.1 | -0.1 |
| 2026Q1 | 4 | 2 | 25.9% | 3.14 | 8.97 | -20.6% | -12.1% | -0.2 | -0.2 |
| 2025Q4 | 4 | 2 | 26.6% | 2.93 | 9.40 | -19.4% | -11.7% | -0.0 | -0.0 |
| 2025Q3 | 4 | 2 | 22.8% | 3.44 | 9.72 | -13.8% | -7.4% | -0.0 | -0.1 |
| 2025Q2 | 4 | 2 | 22.7% | 3.26 | 10.01 | -14.0% | -7.6% | 0.0 | 0.0 |
| 2025Q1 | 4 | 3 | 29.6% | 3.12 | 10.62 | -11.3% | -5.9% | -0.2 | -0.2 |
| 2024Q4 | 4 | 3 | 26.8% | 3.57 | 10.82 | -14.7% | -7.9% | 0.2 | 0.2 |
| 2024Q3 | 5 | 3 | 34.1% | 2.79 | 10.72 | 52.7% | 19.3% | -0.0 | -0.1 |
| 2024Q2 | 6 | 3 | 34.6% | 2.81 | 11.20 | 55.8% | 20.7% | -0.3 | -0.3 |
| 2024Q1 | 6 | 3 | 34.4% | 2.91 | 11.66 | 48.6% | 18.1% | -0.4 | -0.5 |
| 2023Q4 | 6 | 3 | 34.1% | 3.14 | 12.47 | 47.5% | 18.1% | -0.1 | -0.2 |
| 2023Q3 | 6 | 1 | 55.8% | 2.57 | 5.91 | -57.0% | -14.1% | -0.2 | -0.3 |
| 2023Q2 | 5 | 1 | 56.8% | 2.62 | 5.39 | -86.4% | -11.2% | -0.1 | -0.1 |
| 2023Q1 | 5 | 1 | 59.1% | 2.34 | 5.53 | -66.9% | -11.9% | -0.2 | -0.3 |
| 2022Q4 | 5 | 1 | 59.4% | 2.23 | 6.12 | -70.3% | -16.2% | -0.1 | -0.1 |
| 2022Q3 | 5 | 1 | 60.4% | 2.22 | 5.84 | -62.6% | -15.7% | -0.1 | -0.1 |
| 2022Q2 | 5 | 0 | 83.0% | 1.18 | 0.02 | -194.5% | -26.7% | -0.3 | -0.3 |
| 2022Q1 | 3 | 0 | 80.7% | 1.40 | 0.25 | -322.5% | -36.4% | -0.3 | -0.3 |
| 2021Q4 | 3 | 1 | 68.0% | 2.69 | 0.68 | -155.4% | -32.8% | -0.3 | -0.3 |
| 2021Q3 | 3 | 1 | 72.8% | 2.31 | 0.96 | -115.7% | -32.2% | -0.1 | -0.1 |
| 2021Q2 | 3 | 1 | 66.0% | 2.74 | 1.31 | -82.1% | -28.6% | -0.2 | -0.2 |
| 2021Q1 | 2 | 0 | 82.8% | 1.95 | 0.65 | -116.0% | -36.8% | -0.1 | -0.2 |
| 2020Q4 | 3 | 1 | 76.5% | 2.20 | 1.03 | -136.9% | -39.2% | -0.2 | -0.3 |
| 2020Q3 | 3 | 1 | 71.6% | 2.46 | 1.39 | -122.1% | -43.5% | -0.0 | -0.0 |
| 2020Q2 | 3 | 1 | 64.4% | 3.17 | 1.76 | -104.8% | -42.6% | -0.2 | -0.2 |
| 2020Q1 | 4 | 1 | 58.2% | 3.34 | 2.28 | -80.7% | -35.9% | -0.2 | -0.2 |
| 2019Q4 | 3 | 1 | 66.5% | 2.84 | 2.35 | -89.5% | -38.0% | -0.2 | -0.2 |
| 2019Q3 | 4 | 2 | 58.3% | 3.15 | 3.70 | -67.1% | -30.5% | 0.0 | 0.0 |
| 2019Q2 | 4 | 2 | 55.4% | 3.15 | 4.42 | -62.1% | -29.9% | -0.2 | -0.2 |
| 2019Q1 | 4 | 2 | 53.4% | 3.85 | 4.92 | -65.7% | -33.9% | -0.5 | -0.5 |
| 2018Q4 | 5 | 2 | 52.3% | 3.59 | 5.66 | -67.4% | -36.9% | -0.1 | -0.1 |
| 2018Q3 | 6 | 3 | 52.2% | 3.32 | 6.57 | -66.8% | -37.0% | -0.4 | -0.4 |
| 2018Q2 | 6 | 3 | 49.6% | 3.18 | 7.61 | -67.6% | -39.9% | -0.5 | -0.6 |
| 2018Q1 | 7 | 4 | 45.0% | 3.65 | 2.64 | -66.1% | -41.9% | -0.4 | -0.4 |
| 2017Q4 | 8 | 5 | 40.8% | 3.87 | 3.28 | -61.4% | -40.6% | -0.9 | -0.9 |
| 2017Q3 | 9 | 5 | 39.6% | 3.65 | 3.85 | -59.2% | -40.2% | -0.9 | -0.9 |
| 2017Q2 | 10 | 7 | 35.5% | 4.16 | 4.59 | -55.4% | -39.5% | -0.7 | -0.7 |
| 2017Q1 | 11 | 7 | 31.4% | 4.89 | 5.26 | -52.0% | -38.1% | -1.4 | -1.5 |
| 2016Q4 | 13 | 9 | 29.3% | 4.99 | 6.26 | – | – | -1.3 | -1.5 |
| 2016Q3 | 14 | 10 | 27.2% | 6.51 | 6.95 | – | – | -0.8 | -0.8 |